Back to today’s briefing

Story perspectives

AstraZeneca Invests $2.5B in Beijing R&D Center, Creating 1,700 Jobs

3/24/2025

42 10

Summary

Story summary

AstraZeneca is set to make a significant mark in China with a $2.5 billion investment to launch its sixth global R&D center in Beijing. This initiative will drive innovation in early-stage research and AI, collaborating with local biotech firms. The project promises to create 1,700 jobs, underscoring AstraZeneca's dedication to enhancing China's life sciences landscape.

1 of 1

Story summary

AstraZeneca is set to make a significant mark in China with a $2.5 billion investment to launch its sixth global R&D center in Beijing. This initiative will drive innovation in early-stage research and AI, collaborating with local biotech firms. The project promises to create 1,700 jobs, underscoring AstraZeneca's dedication to enhancing China's life sciences landscape.